{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:36:15Z","timestamp":1790120175542,"version":"4.0.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>The present study was performed to compare the optical quality of the eyes of myopic children before and after treatment with atropine eye drops of different concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In the study population of 71 patients (131 eyes), 34 patients (63 eyes) were given 0.01% atropine eye drops and 37 patients (68 eyes) were given 0.05% atropine eye drops. The modulation transfer function (MTF) cutoff frequency, Strehl ratio, objective scattering index (OSI), and predicted visual acuities (PVAs 100%, 20%, and 9%) under different lighting conditions were measured before and after two weeks of atropine treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      After using 0.05% atropine eye drops for two weeks, the Strehl ratio decreased from 0.27 \u00b1 0.07 to 0.23 \u00b1 0.07 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0026), PVA 20% decreased from 1.15 \u00b1 0.32 to 1.03 \u00b1 0.36 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0344), and PVA 9% decreased from 0.74 \u00b1 0.23 to 0.64 \u00b1 0.23 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0073). The OSI was significantly higher after using 0.05% than 0.01% atropine eye drops (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0396), while both the Strehl ratio and PVA 20% were lower after using 0.05% than 0.01% atropine eye drops (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0087 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0492, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The children\u2019s optical quality did not change significantly after using 0.01% atropine eye drops, whereas it decreased after using 0.05% atropine eye drops.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_2886_21","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T07:18:21Z","timestamp":1654067901000},"page":"2107-2110","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Effects of low-concentration atropine eye drops on the optical quality of the eyes in myopic children"],"prefix":"10.4103","volume":"70","author":[{"given":"Weiran","family":"Li","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Ninth People\u2019s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China"},{"name":"Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ninth People\u2019s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China"},{"name":"Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibo","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ninth People\u2019s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China"},{"name":"Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"key":"R1-20251004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1475-1313.2011.00884.x","article-title":"Worldwide prevalence and risk factors for myopia:Prevalence and risk factors for myopia","volume":"32","author":"Pan","year":"2012","journal-title":"Ophthalmic Physiol Opt"},{"key":"R2-20251004","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1475-1313.2005.00298.x","article-title":"Myopia and associated pathological complications","volume":"25","author":"Saw","year":"2005","journal-title":"Oph Phys Optics"},{"key":"R3-20251004","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1167\/iovs.11-8343","article-title":"High prevalence of myopia and high myopia in 5060 Chinese university students in Shanghai","volume":"53","author":"Sun","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R4-20251004","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1167\/iovs.12-10106","article-title":"Prevalence of myopia and its association with body stature and educational level in 19-year-old male conscripts in Seoul, South Korea","volume":"53","author":"Jung","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R5-20251004","doi-asserted-by":"crossref","first-page":"e0130646","DOI":"10.1371\/journal.pone.0130646","article-title":"Correction:Orthokeratology to control myopia progression:A meta-analysis","volume":"10","author":"Sun","year":"2015","journal-title":"PLoS One"},{"key":"R6-20251004","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/OPX.0b013e318242dfbf","article-title":"Peripheral refraction in high myopia with spherical soft contact lenses","volume":"89","author":"Kwok","year":"2012","journal-title":"Optom Vis Sci"},{"key":"R7-20251004","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.ophtha.2012.04.020","article-title":"The association between time spent outdoors and myopia in children and adolescents:A systematic review and meta-analysis","volume":"119","author":"Sherwin","year":"2012","journal-title":"Ophthalmology"},{"key":"R8-20251004","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/jamapediatrics.2019.0278","article-title":"Outdoor activity protects against childhood myopia-let the sun shine in","volume":"173","author":"Zadnik","year":"2019","journal-title":"JAMA Pediatr"},{"key":"R9-20251004","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia","volume":"113","author":"Chua","year":"2006","journal-title":"Ophthalmology"},{"key":"R10-20251004","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","article-title":"Five-year clinical trial on atropine for the treatment of myopia 2:Myopia control with atropine 0.01% eyedrops","volume":"123","author":"Chia","year":"2016","journal-title":"Ophthalmology"},{"key":"R11-20251004","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-concentration atropine for myopia progression (LAMP) study:A randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"key":"R12-20251004","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","article-title":"Efficacy comparison of 16 interventions for myopia control in children:A network meta-analysis","volume":"123","author":"Huang","year":"2016","journal-title":"Ophthalmology"},{"key":"R13-20251004","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/OPX.0b013e3181fc6445","article-title":"Effects of 0.05% racanisodamine on pupil size and accommodation","volume":"87","author":"Chen","year":"2010","journal-title":"Optom Vis Sci"},{"key":"R14-20251004","first-page":"1657","article-title":"The diluted atropine for inhibition of myopia progression in Korean children","volume":"11","author":"Moon","year":"2018","journal-title":"Int J Ophthalmol"},{"key":"R15-20251004","doi-asserted-by":"crossref","first-page":"e0142189","DOI":"10.1371\/journal.pone.0142189","article-title":"Intra- and Intersession Repeatability of an Optical Quality and Intraocular Scattering Measurement System in Children","volume":"10","author":"Tian","year":"2015","journal-title":"PLoS One"},{"key":"R16-20251004","doi-asserted-by":"crossref","first-page":"e16823","DOI":"10.1371\/journal.pone.0016823","article-title":"An objective scatter index based on double-pass retinal images of a point source to classify cataracts","volume":"6","author":"Artal","year":"2011","journal-title":"PLoS One"},{"key":"R17-20251004","first-page":"970","article-title":"An analysis on the equivalence of the eye to a system with aberration","volume":"25","author":"Jiang","year":"1982","journal-title":"Sci Sin B"},{"key":"R18-20251004","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/02713683.2018.1514056","article-title":"Long-term changes in straylight induced by overnight orthokeratology:An objective measure using the double-pass system","volume":"44","author":"Liu","year":"2019","journal-title":"Curr Eye Res"},{"key":"R19-20251004","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s00417-018-4112-8","article-title":"Short-term effects of low-concentration atropine eye drops on pupil size and accommodation in young adult subjects","volume":"256","author":"Kaymak","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R20-20251004","first-page":"1535","article-title":"Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude:Low-dose atropine and myopia progression","volume":"104","author":"Fu","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"R21-20251004","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ophtha.2021.10.016","article-title":"Efficacy and safety of 8 atropine concentrations for myopia control in children:A network meta-analysis","volume":"129","author":"Ha","year":"2022","journal-title":"Ophthalmology"},{"key":"R22-20251004","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s10792-021-01755-8","article-title":"Side effects of topical atropine 0.05% compared to 0.01% for myopia control in German school children:A pilot study","volume":"41","author":"Joachimsen","year":"2021","journal-title":"Int Ophthalmol"},{"key":"R23-20251004","article-title":"The impact of clinical atropine use in Taiwanese school children:Changes in physiological characteristics and visual functions","volume":"8","author":"Kuo","year":"2021","journal-title":"Children (Basel, Switzerland)"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_2886_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:52:09Z","timestamp":1786647129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_2886_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_2886_21","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]},"assertion":[{"value":"2021-11-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}